Utility of Initial Tumor Reduction as a Prognostic Factor in Esophageal Squamous Cell Cancer Patients Undergoing Neoadjuvant Chemotherapy Followed by Surgery : A Retrospective Cohort Study

CONCLUSIONS: Tumor response after the first course of NAC-DCF may be a good predictor of survival in patients with EC who underwent NAC-DCF plus surgery.PMID:38664331 | DOI:10.1245/s10434-024-15314-9

Source: Ann Oncol - April 25, 2024 Category: Cancer & Oncology Authors: Takaomi Hagi Osamu Shiraishi Tomoya Nakanishi Masashi Kohda Yoko Hiraki Hiroaki Kato Atsushi Yasuda Masayuki Shinkai Motohiro Imano Takushi Yasuda Source Type: research